Vial Announces the Addition of Dr. Michael W. Lawlor of the Medical College of Wisconsin and the Diverge Translational Science Laboratory to their Central Nervous System Scientific Advisory Board

SAN FRANCISCO, Dec. 6, 2022 /PRNewswire/ -- Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Michael W. Lawlor, MD, Ph.D., to Vial's central nervous system (CNS) scientific advisory board (SAB). Dr. Lawlor will work...

Click to view original post